Vlasov P K, Orekhova N V, Filatova N V, Leonova M V
Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(3 Suppl 2):44-7.
An aim of the study was to assess clinical-economic effectiveness of therapy in the stages of examination of an epileptic patient by a local neurologist and then by an epileptologist after therapy optimization. Three hundreds and ten patients with different forms of epilepsy and types of epileptic seizures were treated. Costs-of-illness and medical services were assessed using common parameters on the basis of current prices in the health-care system. Special attention was drawn to expenses related to purchasing of antiepileptic drugs (traditional and new ones). The expenses for treatment were compared to treatment effectiveness. It is concluded that mean costs of treatment of epilepsy, including new brands of antiepileptic drugs with high prices, have substantial medical-social benefits that compensate expenses for their purchasing at the expense of other direct and indirect costs.
该研究的一个目的是评估在癫痫患者由当地神经科医生进行检查阶段，以及在治疗优化后由癫痫专家进行检查阶段的治疗临床经济效果。对310例患有不同形式癫痫和癫痫发作类型的患者进行了治疗。基于医疗保健系统的当前价格，使用通用参数评估疾病成本和医疗服务。特别关注了与购买抗癫痫药物（传统药物和新药）相关的费用。将治疗费用与治疗效果进行了比较。得出的结论是，癫痫治疗的平均成本，包括价格高昂的新品牌抗癫痫药物，具有可观的医疗社会效益，这些效益弥补了购买药物所产生的费用，而这些费用是以牺牲其他直接和间接成本为代价的。
